2017 - David M. Livingston

Deputy Director, Dana-Farber Harvard Cancer Center, BOSTON

Dr. Livingston, is honored for his fundamental contributions to the field of basic cancer research. His work has been pivotal to the understanding of retinoblastoma pathway of cell cycle control as well as the transcriptional co-activation function of the key regulatory proteins, p300 and CBP. Dr. Livingston is also credited with the landmark discovery of the central functions of the tumor suppressors, BRCA1 and BRCA2, which has revolutionized the fields of breast and ovarian cancer research.
Dr. Livingston’s stellar reputation as a respected and admired scientist, colleague, and mentor is clearly evident through his continued impact upon scientific endeavors.
Dr. Livingston received an AB cum laude from Harvard College in 1961, an MD, magna cum laude, from Tufts University School of Medicine in 1965, and served his internship and residency in internal medicine at the Peter Bent Brigham Hospital in Boston (now Brigham and Women's Hospital).
Dr. Livingston is the recipient of numerous awards and honors including the AACR G.H.A. Clowes Award in 2005. He has been elected to the National Academy of Medicine, the National Academy of Sciences, and the American Academy of Arts and Sciences.

unchecked checked